BioTelemetry, Inc. Accounts Receivable, Credit Loss Expense (Reversal)

BioTelemetry, Inc. Accounts Receivable, Credit Loss Expense (Reversal)

BioTelemetry, Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $6.46 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ProvisionForDoubtfulAccounts · last filed 2020-10-29

• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2020-09-30 was $6.46M, a 10.36% increase year-over-year.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2020-06-30 was $6.17M, a 14.63% increase year-over-year.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2020-03-31 was $6.02M, a 16.94% increase year-over-year.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2019-12-31 was $5.38M, a 1.36% increase year-over-year.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2019 was $21.77M, a 2.04% decline from fiscal 2018.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2018 was $22.22M, a 67.20% increase from fiscal 2017.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2017 was $13.29M, a 33.83% increase from fiscal 2016.
• BioTelemetry, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2016 was $9.93M, a 23.41% increase from fiscal 2015.